Black Friday

All the Features.
Half the Price.

$149.00 / first year $299.50

Then $299.50/year

Last Close
264.32
Nov 13 • 3:59 PM ET Dollar change+10.88 Percentage change(4.29%)
Aftermarket Close
272.20
Aftermarket • 7:30 PM ET Dollar change+7.88 Percentage change(2.98%)
Index
S&P 500, RUI
Market Cap
25.67B
Enterprise Value
27.20B
Income
827.00M
Sales
6.17B
Book/sh
74.74
Cash/sh
5.47
Employees
17937
IPO
Jun 01, 1992
P/E
31.36
Forward P/E
21.25
PEG
2.14
P/S
4.16
P/B
3.54
P/C
48.33
P/FCF
27.39
EV/EBITDA
15.73
EV/Sales
4.41
Quick Ratio
1.44
Current Ratio
2.05
Debt/Eq
0.28
LT Debt/Eq
0.24
Option/Short
Yes / Yes
EPS (ttm)
8.43
EPS next Y
12.44
EPS next Q
2.79
EPS this Y
12.62%
EPS next Y
8.59%
EPS next 5Y
9.93%
EPS past 3/5Y
95.07% 11.37%
Sales past 3/5Y
9.38% 13.82%
EPS Y/Y TTM
19.88%
Sales Y/Y TTM
8.13%
EPS Q/Q
12.73%
Sales Q/Q
8.79%
Insider Own
0.34%
Insider Trans
-6.29%
Inst Own
100.92%
Inst Trans
-0.97%
ROA
7.83%
ROE
11.59%
ROIC
9.16%
Gross Margin
45.23%
Oper. Margin
20.02%
Profit Margin
13.41%
SMA20
10.44%
SMA50
18.39%
SMA200
17.93%
Trades
Shs Outstand
97.10M
Shs Float
96.78M
52W High
269.44 -1.90%
52W Low
195.14 35.45%
Volatility
2.54% 2.66%
ATR (14)
6.88
RSI (14)
75.69
Beta
0.85
Rel Volume
1.39
Avg Volume
707.13K
Volume
984,573
Perf Week
4.76%
Perf Month
17.83%
Perf Quarter
15.05%
Perf Half Y
24.61%
Perf YTD
4.26%
Perf Year
1.49%
Perf 3Y
30.70%
Perf 5Y
14.15%
Perf 10Y
307.84%
Prev Close
253.44
Price
264.32
Change %
4.29%
Consensus
Buy
Avg. Price Target
$287.33
Implied Upside
+8.7%
Analysts12incl. previous ratings
Rating Distribution8 Buy · 4 Hold · 0 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
TodayUpgrade
JEF logoJJefferies
Hold → Buy$232 → $305+15.4%
Jul 28, 2026Initiated
UBS logoUUBS
Buy$275+4.0%
Jul 15, 2025Upgrade
MS logoMMorgan Stanley
Equal-Weight → Overweight$276+4.4%
May 29, 2025Initiated
JEF logoJJefferies
Hold$263-0.5%
Oct 24, 2024Upgrade
PPiper Sandler
Neutral → Overweight$230 → $260-1.6%
Feb 06, 2024Resumed
KEY logoKKeyBanc Capital Markets
Overweight$253-4.3%
May 30, 2023Initiated
MS logoMMorgan Stanley
Equal-Weight$206-22.1%
Apr 14, 2023Downgrade
PPiper Sandler
Overweight → Neutral$215 → $197-25.5%
Sep 23, 2022Downgrade
NNeedham
Buy → Hold
Jul 14, 2022Initiated
PPiper Sandler
Overweight$240-9.2%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Madsen JuliaOfficerNov 13 '26Proposed Sale260.002,046531,960Nov 13 04:01 PM
Burton Karen LSr. Vice Pres., CFONov 11 '26Option Exercise147.055,880864,65418,836Nov 12 04:32 PM
Burton Karen LSr. Vice Pres., CFONov 11 '26Sale255.625,8801,503,04612,956Nov 12 04:32 PM
Sohi MohsenDirectorNov 10 '26Option Exercise114.744,893561,42329,198Nov 12 04:31 PM
Sohi MohsenDirectorNov 10 '26Sale253.224,8931,239,00824,305Nov 12 04:31 PM
Burton Karen LOfficerNov 11 '26Proposed Sale255.625,8801,503,046Nov 12 10:20 AM
Sohi MohsenDirectorNov 10 '26Proposed Sale253.224,8931,239,012Nov 10 04:15 PM
Breeden Richard CDirectorAug 18 '26Proposed Sale231.904,110953,114Aug 18 05:25 PM
Sohi MohsenDirectorAug 12 '26Option Exercise86.234,058349,92128,363Aug 12 04:33 PM
Sohi MohsenDirectorAug 12 '26Sale235.784,058956,79524,305Aug 12 04:33 PM
Sohi MohsenDirectorAug 12 '26Proposed Sale235.784,058956,779Aug 12 04:06 PM
Zangerle John AdamSr. VP, Gen Counsel, and Sec.Jun 15 '26Sale209.281,419296,96835,259Jun 16 04:31 PM
Zangerle John AdamOfficerJun 15 '26Proposed Sale209.281,419296,968Jun 15 04:06 PM
Carestio Daniel APresident and CEOJun 04 '26Sale214.643,054655,51165,021Jun 08 04:31 PM
Carestio Daniel APresident and CEOJun 05 '26Sale212.001,374291,28863,647Jun 08 04:31 PM
Carestio Daniel AOfficerJun 05 '26Proposed Sale212.001,374291,288Jun 05 04:06 PM
Breeden Richard CDirectorJun 02 '26Option Exercise71.403,781269,96340,445Jun 04 04:31 PM
Breeden Richard CDirectorJun 02 '26Sale209.511,481310,28438,964Jun 04 04:31 PM
Carestio Daniel AOfficerJun 04 '26Proposed Sale214.643,054655,511Jun 04 04:13 PM
Breeden Richard CDirectorJun 02 '26Proposed Sale209.511,481310,285Jun 02 04:18 PM
FELDMANN CYNTHIA LDirectorMar 05 '26Option Exercise152.323,098471,8873,803Mar 06 04:32 PM
FELDMANN CYNTHIA LDirectorMar 05 '26Sale237.213,098734,877705Mar 06 04:32 PM
FELDMANN CYNTHIA LDirectorMar 05 '26Proposed Sale237.213,098734,867Mar 05 04:04 PM
Madsen JuliaSr. VP and GM, Life SciencesNov 21 '25Option Exercise128.225,008642,13913,582Nov 25 04:39 PM
Madsen JuliaSr. VP and GM, Life SciencesNov 21 '25Sale262.005,0081,312,09610,710Nov 25 04:39 PM
Madsen JuliaOfficerNov 21 '25Proposed Sale262.005,0081,312,096Nov 21 04:51 PM
Tamaro RenatoV.P. & Corporate TreasurerNov 18 '25Option Exercise182.223,536644,33010,731Nov 20 04:31 PM
Tamaro RenatoV.P. & Corporate TreasurerNov 18 '25Sale257.555,0361,297,0405,695Nov 20 04:31 PM
Tamaro RenatoOfficerNov 18 '25Proposed Sale257.555,0361,297,033Nov 18 04:46 PM
STERIS Plc engages in the provision of healthcare and life science products and service solutions. It operates through the following segments: Healthcare, Life Sciences, Applied Sterilization Technologies, and Dental. The Healthcare segment provides a comprehensive offering for healthcare providers worldwide, focused on sterile processing departments and procedural centers, such as operating rooms and endoscopy suites. The Life Sciences segment designs, manufactures, and sells consumable products, equipment maintenance, specialty services, and capital equipment. The Applied Sterilization Technologies segment is involved in contract sterilization and testing services for medical device and pharmaceutical manufacturers. The Dental segment offers a comprehensive offering for dental practitioners and dental schools, offering instruments, infection prevention consumables and instrument management systems. The company was founded in 1985 and is headquartered in Dublin, Ireland.
PresidentMr. Daniel A. Carestio
Senior VPMs. Karen L. Burton
Senior VPMr. John Adam Zangerle
SVP & Chief Human Resources OfficerMs. Mary Clare Fraser
Senior VP & President of HealthcareMr. Cary L. Majors